Health

New York approves AI-based breast cancer diagnosis



With the Clinical Laboratory Evaluation Program’s test validation, the company’s Clinical Laboratory Improvement Amendment certified lab can begin testing patient samples.

WHY IT IMPORTANT

Together with the clinical validation and analysis by the New York State Department of Health of the use of this array morphology, the results of the PDxBr trial are reproducible.

Wayne Brinster, CEO of PreciseDx, said: “In line with our mission to improve healthcare, PDxBr has proven to be an effective prognostic tool to further improve risk stratification. risk compared with current histopathological methods”.

The company says AI technology has now proven to enhance the pathological interpretation of invasive breast cancer with objective, quantifiable and accurate data.

“This data, which is also part of a submission to New York State, provides stronger information about a patient’s condition and represents the next generation of pathology analysis.”

TREND TO BIGGER

Artificial intelligence is being used to provide greater accuracy in cancer care from analyzing images to comparing patient and tumor properties to better identify suitable clinical trials as well as improve the speed of treatment.

At HCA Healthcare, identifying newly diagnosed cancer patients proved time-consuming with manual searches through pathology, physician calendars, and referrals.

The AI ​​program pulled out cancer-positive patients from pathology and radiology reports, and alerted navigating nurses about possible cancer diagnoses and results integrated into the HCA’s Meditech electronic health record.

“For HCA, the time from cancer diagnosis to initial treatment,” says Kristina Rua, RN, former director of oncology navigation services at HCA’s East Florida division and now president of Florida. was reduced to 6 days and patient retention increased by 15%. Institute of Cancer Nurse and Patient Navigator.

At a HIMSS21European session on exploring new limits in AI for cancer care, Dr Tufia Haddad of the Mayo Clinic shared that using a clinical trial-appropriate tool not only gives more efficient, but also spend more time on patient care in clinical practice.

“There’s an immediate and lasting impact,” she says.

news7g

News7g: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button